Your browser doesn't support javascript.
loading
Anti-amyloid antibody therapies in Alzheimer's disease.
Perneczky, Robert; Jessen, Frank; Grimmer, Timo; Levin, Johannes; Flöel, Agnes; Peters, Oliver; Froelich, Lutz.
Affiliation
  • Perneczky R; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
  • Jessen F; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich 81377, Germany.
  • Grimmer T; Munich Cluster for Systems Neurology (SyNergy), Munich 81377, Germany.
  • Levin J; Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London W6 8RP, UK.
  • Flöel A; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.
  • Peters O; Department of Psychiatry and Psychotherapy, University of Cologne, Cologne 50937, Germany.
  • Froelich L; German Center for Neurodegenerative Diseases (DZNE) Bonn, Bonn 53127, Germany.
Brain ; 146(3): 842-849, 2023 03 01.
Article in En | MEDLINE | ID: mdl-36655336
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Alzheimer Disease / Cognitive Dysfunction Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Brain Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Alzheimer Disease / Cognitive Dysfunction Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Brain Year: 2023 Type: Article Affiliation country: Germany